Societe Generale Private Banking:企業の戦略・SWOT・財務情報

◆英語タイトル:Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13402
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Societe Generale Private Banking – Strategy, SWOT and Corporate Finance Report
Summary

Societe Generale Private Banking – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Societe Generale Private Banking (SGPB), private bank of Societe Generale Group, provides comprehensive wealth management and private banking services for high net-worth individuals, entrepreneurs, business owners, and people involved in liberal art and media. It also provides wealth management services to ultra-high net-worth individuals. The services include wealth planning, investment solutions, financing solutions, and diversification services. The bank operates through its offices in Belgium, Channel Islands, France, Gibraltar, Ireland, Luxembourg, Monaco, Switzerland, the UK, and Singapore. SGPB is headquartered in Paris, Ile de France, France.

Scope

- Detailed information on Societe Generale Private Banking required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Societe Generale Private Banking in the form of a SWOT analysis
- An in-depth view of the business model of Societe Generale Private Banking including a breakdown and examination of key business segments
- Intelligence on Societe Generale Private Banking’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Societe Generale Private Banking, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Societe Generale Private Banking and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Societe Generale Private Banking as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Societe Generale Private Banking’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Societe Generale Private Banking: Company Overview
Societe Generale Private Banking: Overview and Key Facts
Societe Generale Private Banking: Overview
Societe Generale Private Banking: Key Facts
Societe Generale Private Banking: Key Employees
Societe Generale Private Banking: Key Employee Biographies
Societe Generale Private Banking: Major Products and Services
Societe Generale Private Banking: Company History
Societe Generale Private Banking: Management Statement
Societe Generale Private Banking: Locations and Subsidiaries
Societe Generale Private Banking: Key Competitors
Societe Generale Private Banking: Company Analysis
Societe Generale Private Banking: Business Description
Societe Generale Private Banking: SWOT Analysis
Societe Generale Private Banking: SWOT Overview
Societe Generale Private Banking: Strengths
Societe Generale Private Banking: Weaknesses
Societe Generale Private Banking: Opportunities
Societe Generale Private Banking: Threats
Societe Generale Private Banking: Recent Developments
Societe Generale Private Banking: News and Events Summary
Societe Generale Private Banking: Business Expansion
Societe Generale Private Banking: Corporate Governance
Societe Generale Private Banking: Financial Deals
Societe Generale Private Banking: Financial Performance
Societe Generale Private Banking: Red Flags/DistressSignals
Societe Generale Private Banking: Regulatory and Legal Events
Societe Generale Private Banking: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Societe Generale Private Banking: Key Facts
Table 2: Societe Generale Private Banking: Key Employees
Table 3: Societe Generale Private Banking: Company History
Table 4: Societe Generale Private Banking: Locations and Subsidiaries
Table 5: Societe Generale Private Banking: Key Competitors
Table 6: Societe Generale Private Banking: News and Events Summary
Table 7: Societe Generale Private Banking: Business Expansion
Table 8: Societe Generale Private Banking: Corporate Governance
Table 9: Societe Generale Private Banking: Financial Deals
Table 10: Societe Generale Private Banking: Financial Performance
Table 11: Societe Generale Private Banking: Red Flags/DistressSignals
Table 12: Societe Generale Private Banking: Regulatory and Legal Events
Table 13: Societe Generale Private Banking: Strategy and Operations



★海外企業調査レポート[Societe Generale Private Banking:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BioInvent International AB (BINV):製薬・医療:M&Aディール及び事業提携情報
    Summary BioInvent International AB (BioInvent) focuses on the discovery and development of antibody drugs for the treatment of cancer. The company uses n-CoDeR, its inhouse platform for developing immuno-oncology drugs. n-CoDeR is an antibody library used for the rapid selection, screening and ident …
  • Cerus Corp (CERS)-医療機器分野:企業M&A・提携分析
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family he …
  • Loblaw Companies Limited:企業の戦略・SWOT・財務情報
    Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report Summary Loblaw Companies Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gulf Pharmaceutical Industries PSC (JULPHAR):企業の財務・戦略的SWOT分析
    Gulf Pharmaceutical Industries PSC (JULPHAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Endress+Hauser AG:企業の戦略的SWOT分析
    Endress+Hauser AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Huegli Holding AG:企業の戦略・SWOT・財務情報
    Huegli Holding AG - Strategy, SWOT and Corporate Finance Report Summary Huegli Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Osiris Therapeutics Inc (OSIR):企業の財務・戦略的SWOT分析
    Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Welltower Inc:企業のM&A・事業提携・投資動向
    Welltower Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Welltower Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Charter Communications Inc (CHTR):企業の財務・戦略的SWOT分析
    Charter Communications Inc (CHTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Chokwang Paint Co Ltd (004910):企業の財務・戦略的SWOT分析
    Chokwang Paint Co Ltd (004910) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Varian Medical Systems, Inc.:企業の戦略・SWOT・財務情報
    Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Varian Medical Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …
  • InteRNA Technologies BV-製薬・医療分野:企業M&A・提携分析
    Summary InteRNA Technologies BV (InteRNA) is a biotechnology company that specializes in the development of RNA therapeutics for the treatment of cancer. The company develops technologies in biomedical research translating miRNA sequence fields. Its drug development programs focuses on developing mi …
  • Split Rock Partners, LLC:企業の戦略・SWOT・財務分析
    Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report Summary Split Rock Partners, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Binx Health Inc:企業の製品パイプライン分析
    Summary Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for women’s health. The company develops its proprietary, desktop, PCR-based point-of-care molecular diagnostic platform for diagnosis and treatment for chl …
  • La Plata Electric Association, Inc.:企業の発電所・SWOT分析2018
    La Plata Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • JinkoSolar Holding Co Ltd (JKS):電力:M&Aディール及び事業提携情報
    Summary JinkoSolar Holding Co Ltd (JinkoSolar) is a manufacturer of solar products. The company is involved in manufacturing and marketing of solar power products such as silicon ingots, silicon wafers, solar modules, solar PV cells, and monocrystalline and multicrystalline photovoltaic (PV) panels. …
  • Noble Life Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noble Life Sciences Inc (Noble Life Sciences) is a contract research organization that offers vaccines, drugs, and medical device development services. The company provides preclinical services such as disease and animal models, drug pharmacology and exploratory toxicology, analytical and la …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆